Patents by Inventor James Samuelson

James Samuelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943303
    Abstract: Methods are provided for engineering novel strand-specific nicking endonucleases by means of an in vivo enrichment of a plasmid library containing a randomly mutagenized restriction endonuclease gene. The plasmids contain adjacent to the gene a cleavable or nickable sequence for cleaving or nicking by the endonuclease product of the gene and a second recognition site for a second endonuclease. The plasmid library is used to transform unmodified host cells. Plasmids from the cultured transformed cells may be analyzed by an in vitro assay for nicking and the nicked plasmids pooled and used to transform host cells. The product is then pooled and the single-stranded specificity of the endonuclease is then determined. The product is either cloned after amplification or identified by use of a selectable marker.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: May 17, 2011
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, James Samuelson
  • Patent number: 7011966
    Abstract: The present invention relates to recombinant DNA encoding the AcuI restriction endonuclease as well as AcuI methylase, and expression of AcuI restriction endonuclease and AcuI methylase in E. coli cells containing the recombinant DNA.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: March 14, 2006
    Assignee: New England Biolabs, Inc.
    Inventors: James Samuelson, Shuang-yong Xu, Diana O'Loane
  • Publication number: 20050164186
    Abstract: Methods and compositions are provided for altering the DNA recognition and cleavage characteristics of an endonuclease without prior knowledge of the endonuclease's three-dimensional structure and/or amino acid residues responsible for activity and/or specificity. Methods include subjecting a mutagenized endonuclease gene library to a genetic selection in prokaryotic cells which tolerate the expression of mutated endonuclease and where the endonuclease is active and determining the altered recognition-site specificity for the endonuclease.
    Type: Application
    Filed: January 9, 2003
    Publication date: July 28, 2005
    Inventors: James Samuelson, Shuang-yong Xu
  • Publication number: 20050158834
    Abstract: Methods are provided for engineering novel strand-specific nicking endonucleases by means of an in vivo enrichment of a plasmid library containing a randomly mutagenized restriction endonuclease gene. The plasmids contain adjacent to the gene a cleavable or nickable sequence for cleaving or nicking by the endonuclease product of the gene and a second recognition site for a second endonuclease. The plasmid library is used to transform unmodified host cells. Plasmids from the cultured transformed cells may be analyzed by an in vitro assay for nicking and the nicked plasmids pooled and used to transform host cells. The product is then pooled and the single-stranded specificity of the endonuclease is then determined. The product is either cloned after amplification or identified by use of a selectable marker.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 21, 2005
    Applicant: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, James Samuelson
  • Publication number: 20040219584
    Abstract: Methods are provided for altering the cleavage specificity of a Type IIG restriction endonuclease, the Type IIG restriction endonuclease being characterized by a cleavage domain adjacent to a methylase domain, the methylase domain located adjacent to a specificity domain. The method includes ligating DNA or protein sequences to form a fusion DNA or fusion protein. Where a fusion DNA is formed, the host cell is transformed with the fusion DNA to express a Type IIG restriction endonuclease with altered cleavage specificity.
    Type: Application
    Filed: March 15, 2004
    Publication date: November 4, 2004
    Inventors: Shuang-yong Xu, Daniela Kobbe, Zhenyu Zhu, James Samuelson
  • Publication number: 20040209257
    Abstract: The present invention relates to recombinant DNA encoding the AcuI restriction endonuclease as well as AcuI methylase, and expression of AcuI restriction endonuclease and AcuI methylase in E. coli cells containing the recombinant DNA.
    Type: Application
    Filed: April 16, 2003
    Publication date: October 21, 2004
    Inventors: James Samuelson, Shuang-Yong Xu, Diana O'Loane
  • Patent number: 6794172
    Abstract: The present invention relates to recombinant DNA encoding the PpuMI restriction endonuclease as well as PpuMI methylase, expression of PpuMI restriction endonuclease and PpuMI methylase in E. coli cells containing the recombinant DNA.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: September 21, 2004
    Assignee: New England Biolabs, Inc.
    Inventors: James Samuelson, Shuang-yong Xu
  • Publication number: 20040175816
    Abstract: The present invention relates to recombinant DNA encoding the OkrAI restriction endonuclease as well as OkrAI methylase, expression of OkrAI restriction endonuclease in E. coli cells containing the recombinant DNA.
    Type: Application
    Filed: March 3, 2003
    Publication date: September 9, 2004
    Applicant: New England Biolabs, Inc.
    Inventors: Shuang-Yong Xu, Jian-Ping Xiao, Rebecca B. Kucera, James Samuelson
  • Publication number: 20030215907
    Abstract: The present invention relates to recombinant DNA encoding the PpuMI restriction endonuclease as well as PpuMI methylase, expression of PpuMI restriction endonuclease and PpuMI methylase in E. coli cells containing the recombinant DNA.
    Type: Application
    Filed: May 17, 2002
    Publication date: November 20, 2003
    Applicant: New England Biolabs, Inc.
    Inventors: James Samuelson, Shuang-Yong Xu
  • Patent number: 6403354
    Abstract: The present invention relates to recombinant DNA which encodes the BstYI restriction endonuclease as well as BstYI methyltransferase, expression of BstYI restriction endonuclease and M.BstYI in E. coli cells containing the recombinant DNA. It also relates to methods for purification of the recombinant BstYI restriction endonuclease and BstYI methyltransferase.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: June 11, 2002
    Assignee: New England Biolabs, Inc.
    Inventors: Shuang-yong Xu, James Samuelson, John Pelletier, Marion Sibley, Geoffrey G. Wilson